Area of research
Cancer Research · Genetics
Research interest
Research focused on Glioma and Cancer research, with related work in microRNA, Gene knockdown, Neuroprotection. Notable publications include 'Baicalin ameliorates neuropathology in repeated cerebral ischemia-reperfusion injury model mice by remodeling the gut microbiota', 'miR-124 inhibits the growth of glioblastoma through the downregulation of SOS1', and 'MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated...'.
Bioinformatics insights into ACSL1 and ACSL5: prognostic and immune roles in low-grade glioma
The Spatial Distribution of Brain Metastasis Is Determined by the Heterogeneity of the Brain Microenvironment
Doramectin inhibits glioblastoma cell survival via regulation of autophagy <i>in vitro</i> and <i>in vivo</i>
New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction
MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated fibroblasts
Circular RNA circHECTD1 facilitates glioma progression by regulating the miR‐296‐3p/SLC10A7 axis
Baicalin ameliorates neuropathology in repeated cerebral ischemia-reperfusion injury model mice by remodeling the gut microbiota
Circular RNA circMAN2B2 facilitates glioma progression by regulating the miR‐1205/S100A8 axis
High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma
MiR-124 inhibits cell proliferation, invasion, and migration in glioma by targeting Smad2.
PubMed 2017cited by 7position: first
miR-124 inhibits the growth of glioblastoma through the downregulation of SOS1